ENVALITH
三京化成株式会社 logo

SANKYO KASEI CORPORATION

8138Standard MarketWholesale Trade

三京化成株式会社 logo
SANKYO KASEI CORPORATION8138

Business

Sankyo Kasei Co., Ltd. is a specialty chemical trading company founded in 1946, operating two segments: the Science Business and the Building Interior Materials Business. In the Science Business, the company sells functional chemicals, raw materials, and materials to the Civil Engineering & Building Materials, Information & Transport Equipment, Daily Necessities, and Chemical Industry fields, while the Building Interior Materials Business handles the sale of Housing Components as well as the manufacture and sale of woodworking products. In addition to five domestic locations, the company has five overseas locations in Singapore, Shanghai, Thailand, Vietnam, and Korea (liaison office), and conducts import/export transactions centered on Southeast Asia. Consolidated net sales for FY2026 (ending March 2026) were ¥27,200 million. Major customers are manufacturers in the automotive, electronic components, building materials, and chemical industry sectors.

Business Model

Despite being a trading company, it has maintained an in-house testing laboratory since its founding and conducts sales centered on technical consulting. It creates added value by providing manufacturers with customer needs and technical information, collaborating on new product development, and offering specialized technical services to customers. While the resale of purchased goods forms the core of its business, it also incorporates manufacturer functions (woodworking product manufacturing) through its subsidiary Kyowa Co., Ltd. Handling of imported goods through four overseas subsidiaries is also one of its sources of revenue.

Company Strengths

Since its founding in 1946, the company has maintained an in-house testing laboratory and consistently pursued sales centered on technical consulting. Over approximately 80 years, it has built up a track record of value-added sales that differs from simple distribution operations, including new product development in collaboration with manufacturers and the provision of specialized technical services to customers. This deep technical relationship with customers serves as a barrier to entry for competitors.

The company progressively established wholly-owned local subsidiaries in Singapore (2002), Shanghai (2007), Thailand (2010), and Vietnam (2023), and will open a liaison office in South Korea in April 2026. By linking five overseas locations with five domestic locations, the company conducts transactions for import/export and for companies expanding overseas, having built its own sales infrastructure capable of capturing overseas demand even amid a shrinking domestic economy.

In December 2015, the company made Kyowa Co., Ltd. a wholly-owned subsidiary, bringing the manufacturing and sales functions for woodworking products into the group. By combining trading company functions with manufacturing functions, the company is able to provide value-added services beyond simple intermediation, forming the foundation for improved profitability in the Building Interior Materials Business. In addition, Daido Kogyo Co., Ltd. handles storage, sorting/packing, and shipping of Housing Components, internalizing logistics functions as well.

ENVALITH's Perspective

Of the ¥752 million in profit attributable to owners of parent recorded in FY2026 (ended March 2026), gain on sale of investment securities of ¥446 million (contributing over ¥400 million in cash on a net basis) was a major contributor. For FY2027 (ending March 2027), the company does not anticipate a similar gain on sale and has set its net profit forecast at ¥391 million (down 48.0% year on year). On an operating profit basis, the forecast calls for an increase to ¥528 million (up 2.9% year on year), and the decline below ordinary profit can be explained as resulting from the fading of a one-time factor. Nevertheless, investors need to accurately recognize the substantial decline in net profit.

Operating profit in the Science Business rose 27.4% year on year to ¥616 million, performing well, with segment margin also improving. Meanwhile, the Building Interior Materials Business saw net sales decline 15.4% year on year to ¥3,678 million, with operating profit plunging 47.6% year on year to ¥109 million, a sharp deceleration. The main cause was sluggish shipments of Fixture Materials-related Products and housing-related products, and as an external factor, the slump in domestic housing starts may have had an impact. The outlook for recovery in the Building Interior Materials Business could pose a downside risk to FY2027 (ending March 2027) results.

In FY2025 (ended March 2025), the company spent ¥1,806 million on share buybacks, but this was significantly reduced to ¥76 million in FY2026 (ended March 2026). Total dividends paid also decreased from ¥101 million to ¥89 million, and the payout ratio fell from 18.1% to 12.0%. While the dividend per share was increased from ¥90 to ¥100, total shareholder returns declined due to the substantial reduction in share buybacks. For FY2027 (ending March 2027), the company forecasts maintaining the dividend per share at ¥100, but due to the significant decline in net profit, the payout ratio is expected to rise to over 25%, and the sustainability of the return level warrants close attention.

Growth Strategy

Pursuing a three-pronged approach combining new development of functional products, utilization of overseas bases, and improved capital efficiency

Continuing to expand transactions of new products in multiple fields including transport equipment-related, chemical industry-related, and textile-related businesses. In FY2026 (ending March 2026), Science Business net sales increased 3.3% year on year, reflecting the results of new business development. In FY2027 (ending March 2027), the company will continue to pursue growth with a target of net sales of ¥280,000 million (up 2.9% year on year).

Utilizing overseas bases in Southeast Asia to expand local sales networks for functional products. The company states it will continue to focus on expanding transactions of new functional products both domestically and overseas, positioning the utilization of overseas bases as a medium- to long-term pillar supporting growth of the Science Business.

Promoting the partial sale of policy-held shares with the aim of improving capital efficiency. In FY2026 (ending March 2026), the company recorded a gain on sale of investment securities of ¥446 million, improving the equity ratio to 59.6%. While no similar sales are currently anticipated in FY2027 (ending March 2027), the medium- to long-term policy of reducing shareholdings will continue.

Continuing company-wide efforts to optimize costs, aiming to improve the operating margin through thorough management of selling, general and administrative expenses. In FY2026 (ending March 2026), the company achieved a slight decrease in cost of sales (down 0.2% year on year) and an increase in gross profit (up 5.2% year on year), improving the operating margin from 1.7% to 1.9%.

Last updated: July 19, 2026